Caffeinum Pellet
NDC 63545-620
Product Information
Caffeinum is a UNAPPROVED HOMEOPATHIC-approved product labeled by Hahnemann Laboratories, Inc.. This medication is typically used as a central nervous system stimulant [epc]. It is supplied as a white pellet for oral administration. This product entry covers the primary NDC 63545-620 and 4 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
3 MM
2 MM
Code Structure Chart
Product Details
What is NDC 63545-620?
What are Active Ingredients of this product?
- CAFFEINE 1 [hp_M]/1 - A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CAFFEINE (UNII: 3G6A5W338E)
- CAFFEINE (UNII: 3G6A5W338E) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SUCROSE (UNII: C151H8M554)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.